Elevated plasma ferritin in elderly individuals with high neocortical amyloid-beta load
K Goozee, P Chatterjee, I James, K Shen, HR Sohrabi, PR Asih, P Dave, C ManYan, K Taddei, SJ Ayton, ML Garg, JB Kwok, A Bush, R Chung, JS Magnussen, RN Martins
Molecular Psychiatry | NATURE PUBLISHING GROUP | Published : 2018
This study was funded by the Anglicare, Sydney, the McCusker Alzheimer Research Foundation (MARF), Perth and the KaRa Institute of Neurological Diseases (KaRa MINDS), Sydney. We sincerely thank Professor David Lovejoy for reviewing the manuscript. We thank the participants and their families for their participation and cooperation, and the Anglicare, KaRa MINDS and MARF research and support staff for their contributions to this study. We specially thank Bethany Ball, Emma Toovey, Kate Fredericks and Catherine Brown for their contributions to this study. We also thank the staff of the Macquarie Medical Imaging centre in Macquarie University Hospital, Sydney, for their contributions. KG is a recipient of the Cooperative Research Centre for Mental Health top-up scholarship. AIB is funded by the Australian National Health and Medical Research Council. Florbetaben is a proprietary PET radiopharmaceutical owned by Piramal Imaging SA. For this study, Florbetaben was manufactured and supplied under GMP conditions by Cyclotek (Aust) Pty Ltd.